CREATOR|TITLE|URL|URN|OKKAM|IPR|QUALITY STAMP|RESOURCE LANGUAGE|METADATA LANGUAGE|AUTHOR|DATE|CITATION|KEYWORDS|EDUCATIONAL DESCRIPTION|TECHNICAL DESCRIPTION|RESOURCE TYPE|DISCIPLINE|SPECIALTY|EDUCATIONAL LEVEL|EDUCATIONAL CONTEXT|EDUCATIONAL INSTRUCTIONS|EDUCATIONAL OBJECTIVES|LEARNING OUTCOMES|ASSESSMENT METHODS|EDUCATIONAL PREREQUISITES|REPURPOSED FROM|REPURPOSING CONTEXT|REPURPOSING DESCRIPTIONMarios Neofytou|Ultrasound Image Analysis using Despeckle Filtering and Segmentation|http://moodle.cs.ucy.ac.cy|||||English|English|||||||||||||||||||
Marios Neofytou|ARTIAL SEPTAL DEFECT|http://moodle.cs.ucy.ac.cy|||||English|English|||||||||||||||||||
Marios Neofytou|HYPERTENSION AND CORONARY HEART DISEASE|http://moodle.cs.ucy.ac.cy|||||English|English|||||||||||||||||||
Marios Neofytou|Medical Learning Course|http://moodle.cs.ucy.ac.cy/|||||English|English|||||||||||||||||||
Marios Neofytou|M-Health, e-Emergency Systems and Services|http://moodle.cs.ucy.ac.cy/|||||English|English|||||||||||||||||||
Marios Neofytou|Endoscopy/Hysteroscopy|http://moodle.cs.ucy.ac.cy/|||||Greek|Greek|||||||||||||||||||
Marios Neofytou|E-learning System for Training Doctors the basics of Health Telematics|http://moodle.cs.ucy.ac.cy/|||||English|English|||||||||||||||||||
Dora Edreva|VOT Abbreviations|http://moodle-pld.co.cc/file.php/3/231-238.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-22|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Ventilation/oxygenation therapy  terminology; neonatal, paediatric, intensive care terminology; abbreviations|Main points: Review of the used basic terminology abbreviations|Power Point Presentation|chapter of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Additional information for clarifying the content of the book and of the used abbreviations and terminology for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD  Abbrevitations,|different technology,different language|Power Point Presentation
Dora Edreva|INFORMATIONAL TECHNOLOGIES AND VOT|http://moodle-pld.co.cc/file.php/3/206-230.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-22|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст||Ventilation/oxygenation therapy; neonatal, paediatric, intensive care; medical, monitoring and life-support equipment; medical images, telemedicine, patient databases /PDB/, protocols|Power Point Presentation|chapter of book|Medicine||PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 26,|different language,different technology|Power Point Presentation
Dora Edreva|VOT - Home care|http://moodle-pld.co.cc/file.php/3/204-205.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-22|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Ventilation/oxygenation therapy; neonatal, paediatric, intensive care; medical, monitoring and life-support equipment; home care ventilators, respiratory support, home care logistics|Main points: 1. Home care ventilators; 2. Patients, suitable for VOT|Power Point Presentation|chapter of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 25,|different language,different technology|Power Point Presentation
Dora Edreva|VOT and transport|http://moodle-pld.co.cc/file.php/3/199-203.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-22|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Ventilation/oxygenation therapy; neonatal, paediatric, intensive care; medical, monitoring and life-support equipment; non-invasive, invasive methods, mobile ICU, transport  monitoring, transport|Main points: 1.Special features and problems; 2. Considerations for reducing risks during transport; 3.VOT during transport; 4. Conception for “mobile ICU”; 5. Transport monitoring; 6. Transport module for neonatal and paediatric intensive practice|Power Point Presentation|chapter of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 24,|different language,different technology|Power Point Presentation
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD  Abbrevitations|http://moodle-pld.co.cc/file.php/3/Abbreviations.pdf|||ISBN 954-9806-38-3||Bulgarian|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv||Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст||||chapter of book|Medicine|Neonatology, Paediatrics, Intensive  Care||||||||||
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 26|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter26.pdf|||ISBN 954-9806-38-3||Bulgarian|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv||Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст||||chapter of book|Medicine|Neonatology, Paediatrics, Intensive  Care||||||||||
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 25|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter25.pdf|||ISBN 954-9806-38-3||Bulgarian|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv||Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст||||chapter of book||||||||||||
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 24|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter24.pdf|||ISBN 954-9806-38-3||Bulgarian|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv||Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст||||chapter of book|Medicine|Neonatology, Paediatrics, Intensive  Care||||||||||
Dora Edreva|VOT and diagnostic/therapeutic procedures|http://moodle-pld.co.cc/file.php/3/197-198.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-22|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Ventilation/oxygenation therapy; neonatal, paediatric, intensive care;,  Diagnostic and therapeutic procedures|Main points: 1.Main measures to prevent disturbances; 2. Specific ventilators for VOT during MRI /Magnetic Resonance Imaging/|Power Point Presentation|chapter of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 23,|different language,different technology|Power Point Presentation
Dora Edreva|VOT and thermal comfort|http://moodle-pld.co.cc/file.php/3/191-196.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-22|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Ventilation/oxygenation therapy; neonatal, paediatric, intensive care; hypothermia, hyperthermia ,termal comfort, tempersture monitoring|Main points: 1.Thermal losses; 2. Control on T of IV lines;
 3. Therapeutic hypothermia; 4.Hyperthermia; 5. Drugs; 6. Thermal monitoring; 7. Protocols for monitoring|Power Point Presentation|chapter of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 22,|different language,different technology|Power Point Presentation
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 23|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter23.pdf|||ISBN 954-9806-38-3||Bulgarian|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-22|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст||||chapter of book|Medicine|Neonatology, Paediatrics, Intensive  Care||||||||||
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 22|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter22.pdf|||ISBN 954-9806-38-3||Bulgarian|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-22|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст||||chapter of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists||||||||different language,different technology|
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 21|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter21.pdf|||ISBN 954-9806-38-3||Bulgarian|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-22|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст||||chapter of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists||||||||different language,different technology|
Dora Edreva|VOT and drug therapy|http://moodle-pld.co.cc/file.php/3/184-190.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-22|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Ventilation/oxygenation therapy; neonatal, paediatric, intensive care;drug monitoring, neonatal abstinence, score|Main points: 1.Maternal therapy  - breast feeding; 2. Neonatal abstinence – special scales; 3. Blood and blood products as a part of oxygenation therapy; 4. Drug monitoring|Power Point Presentation|chapter of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 21,|different technology,different language|Power Point Presentation
Dora Edreva|CONTROLLED VARIABLES, DETERMINANTES OF THE OXYGENATION AND CALCULATED INDICES part3|http://moodle-pld.co.cc/file.php/3/40-48.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-25|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Ventilation/oxygenation therapy; neonatal, paediatric, intensive care; medical, monitoring and life-support equipment; non-invasive, invasive methods|Main points:1. MAP is a function of insufflation pressures; 2. Optimal MAP; 3. Oxygenation Index /OI/; 4. Method of choice for conducting Oxygen Therapy; 5. VI/VEI|Power Point Presentation|chapter of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 3,|different technology,different language|Power Point Presentation
Dora Edreva|CONTROLLED VARIABLES, DETERMINANTES OF THE OXYGENATION AND CALCULATED INDICES part2] CONTROLLED VARIABLES, DETERMINANTES OF THE OXYGENATION AND CALCULATED INDICES part2|http://moodle-pld.co.cc/file.php/3/32-39.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-25|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Controlled variables , peak inspiratory pressure /PIP/, positive end-expiratory pressure /PEEP/, frequency /Fr/,  repiratory rate /RR/,  tidal volume /TV/,  flow, compliance /C/, time constant /Tc/,  mean airway pressure /MAP/, arterio/alveolarmratio /a/A/, alveolar-to-arterial partial oxygen tension difference /AaDO2/, ventilation index /VI/, ventilation efficiency index /VEI/|Main points: 1. Tidal volume; 2. Pulmonary volumes, 3. Flow;         4.Compliance;  5. Resistance; 6. MAP|Power Point Presentation|chapter of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 3,|different technology,different language|Power Point Presentation
Dora Edreva|CONTROLLED VARIABLES, DETERMINANTES OF THE OXYGENATION AND CALCULATED INDICES|http://moodle-pld.co.cc/file.php/3/19-31.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-25|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Controlled variables , peak inspiratory pressure /PIP/, positive end-expiratory pressure /PEEP/, frequency /Fr/,  repiratory rate /RR/,  tidal volume /TV/,  flow, compliance /C/, time constant /Tc/,  mean airway pressure /MAP/, arterio/alveolarmratio /a/A/, alveolar-to-arterial partial oxygen tension difference /AaDO2/, ventilation index /VI/, ventilation efficiency index /VEI/|Main points: 1. Effects of PIP – low/high PIP – advantages and side effects; 2. How to determine PIP; 3. Physiological effects of PEEP; optimal PEEP; 4. Change in frequency - reflections|Power Point Presentation|chapter of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 3,|different technology,different language|Power Point Presentation
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter3|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter3.pdf|||ISBN 954-9806-38-3||Bulgarian|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv||Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст||||chapter of book|Medicine|Neonatology, Paediatrics, Intensive  Care||||||||||
Dora Edreva|VOT and nutrition|http://moodle-pld.co.cc/file.php/3/170-183.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-23|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Ventilation/oxygenation therapy; neonatal, paediatric, intensive care; medical, monitoring and life-support equipment; non-invasive, invasive methods, nutrition, feeding, sub-nutritional quantities,  minimal nutrition,Protein-Calorie Malnutriton – PCM, TPN|Main points: 1. Enteral- parenteral nutrition; 2. VOT and special conditions; 3. Fluid therapy; 4. PCM; 5. TPN protocols; 6. TPN complications; 7. Metabolic parameters|Power Point Presentation|chaper of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 20,|different language,different technology|Power Point Presentation
Dora Edreva|VOT NEUROLOGICAL  MONITORING|http://moodle-pld.co.cc/file.php/3/163-169.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-23|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Ventilation/oxygenation therapy; neonatal, paediatric, intensive care; medical, monitoring and life-support equipment; non-invasive, invasive methodsр , ICP – Intra Cranial Pressure, ICPP – IC  perfusion pressure  , DSVN – Distress Scale for Ventilated Newborn Infants, NIPS – Neonatal Infant Pain Score, Infant Distress Score|Main points: 1. Methods of monitoring; 2. VOT and pain: 
a/ Assessment of pain; b/ Pain indicators; c/ Scales and system for evaluating pain; d/ measures for pain relief|Power Point Presentation|chaper of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 18 19,|different language,different technology|Power Point Presentation
Dora Edreva|PRINCIPLES OF MONITORING VOT|http://moodle-pld.co.cc/file.php/3/134-162.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-23|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст||Ventilation/oxygenation therapy; neonatal, paediatric, intensive care; medical, monitoring and life-support equipment; non-invasive, invasive methods,|Power Point Presentation|chaper of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 15 16,|different language,different technology|Power Point Presentation
Dora Edreva|CARE FOR VENTILATED PAIENT|http://moodle-pld.co.cc/file.php/3/124-133.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-23|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Ventilation/oxygenation therapy; neonatal, paediatric, intensive care; medical, monitoring and life-support equipment; non-invasive, invasive methods, delivery room care, ICU care, home care, special care, intubation, extubation, general care, ventilator dependency|Main points: 1.Delivery room care; 2. ICU care; 3. Home care; 4. Special care; 5. Intubation; 6. General care; 7. Weaning from ventilation; 8. Criteria for weaning and extubation; 9. Difficulties in weaning; 10. Complications; 11.Ventilatory settigs and therapy; 
12 Extubation|Power Point Presentation|chaper of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 13 14,|different language,different technology|Power Point Presentation
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 20|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter20.pdf|||ISBN 954-9806-38-3||Bulgarian|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv||Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст||||chaper of book||||||||||||
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 18 19|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter18_19.pdf|||ISBN 954-9806-38-3||Bulgarian|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv||Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст||||chaper of book||||||||||||
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 15 16|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter15_16.pdf|||ISBN 954-9806-38-3||Bulgarian|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv||Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст||||chaper of book||||||||||||
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 13 14|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter13_14.pdf|||ISBN 954-9806-38-3||Bulgarian|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv||Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст||||chaper of book||||||||||||
Dora Edreva|VOT COMPLICATIONS|http://moodle-pld.co.cc/file.php/3/114-123.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-23|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Ventilation/oxygenation therapy; neonatal, paediatric, intensive care; medical, monitoring and life-support equipment; non-invasive, invasive methods barotrauma, intubation, extubation, oxygen toxicity, infection,cardiovascular disturbances,|Main points: 1.VOT complications; 2. Barotreuma; 3. Oxygen toxicity; 4. Infection; 5. Cardiovascular disturbances|Power Point Presentation|book,lecture presentation,chaper of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter11 12,|different language,different technology|Power Point Presentation
Dora Edreva|VENTILATION/OXYGENATON THERAPY AND SURFACTANT|http://moodle-pld.co.cc/file.php/3/104-113.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-23|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Ventilation/oxygenation therapy; neonatal, paediatric, intensive care; medical, monitoring and life-support equipment; non-invasive, invasive methods, surfactant|Main points: 1. Efficacy of surfactant; 2. Implementation of surfactant; 3.Optimal timing; 4. Management of VOT during surfactant therapy; 5.Combined methods; 6. Protocol of effective dose; .|Power Point Presentation|book,lecture presentation,chaper of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter10,|different language,different technology|Power Point Presentation
Dora Edreva|Perfluorocarbon Ventilation, Liquid Ventilation – LV|http://moodle-pld.co.cc/file.php/3/91-103.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-23|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Ventilation/oxygenation therapy; neonatal, paediatric, intensive care; medical, monitoring and life-support equipment; non-invasive, invasive methods, perfluorocarbon ventilation,liquid ventilation /LV/, perfluorocarbons /PFCs/, tidal liquid ventilation /TLV/, partial liquid ventilation /PLV/, perfluorocarbon associated gas exchange /PAGE/|Main points: 1What are PFCs; 2. Different techniqques – TLV/TLB; PLV/PAGE; 3. Effects of LV on surfactant;4. PFC and medical images techniques; 5. PFC and drug therapy; 6. TLV; 7. PAGE – advantages; 8. Evaporation of PFC during PLV; 9. LV indications and patients criteria; 10. Combined techniques|Power Point Presentation|book,lecture presentation,chaper of book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter9,|different language,different technology|Power Point Presentation
Dora Edreva|ЕxtraCorporeal Membrane Oxygenation - ЕСМО|http://moodle-pld.co.cc/file.php/3/82-90.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-25|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Ventilation/oxygenation therapy; neonatal, paediatric, intensive care; medical, monitoring and life-support equipment; non-invasive, invasive methods, еxtracorporeal membrane oxygenation /ECMO/ ,oxygen delivery, anticoagulant therapy|Main points: 1. Indications for ECMO; 2. Selection criteria; 3. ECMO – a/contraindications; b/ steps; c/complications; d/ monitoring; 
4.Weaning neonates from ECMO|Power Point Presentation|book,lecture presentation|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter8,|different language,different technology|Power Point Presentation
Dora Edreva|High Frequency Ventilation - HFV|http://moodle-pld.co.cc/file.php/3/68-71.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-13|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Ventilation/oxygenation therapy; neonatal, paediatric, intensive care; medical, monitoring and life-support equipment; non-invasive, invasive methods, high frequency ventilation /HFV/,  high frequency jet ventilation /HFJV/, high frequency oscillatory ventilation /HFOV/, high frequency flow interruptors /HFFI/, high frequency  positive pressure ventilation /HFPPV/,  high frequency  chest wall oscillation /HFCWO/|Main points: 1. Indications for HFV; 2.Advantages/disadvantages of HFJV; 3. Weaning from HFJV; 4. Advantages/disadvantages of HFOV; 5.HFV side effects and complications; 6.HFV monitoring|Power Point Presentation|book,lecture presentation|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter7,VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter6,|different language,different technology|Power Point Presentation
Dora Edreva|Patient Triggered Ventilation -PTV|http://moodle-pld.co.cc/file.php/3/62-68.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-11|Л. Деспотова-Толева Вентилаторна/оксигенационна терапия в детската възраст|Ventilation/oxygenation therapy; neonatal, paediatric, intensive care; medical, monitoring and life-support equipment; non-invasive, invasive methods, synchronous intermittent mandatory ventilation /SIMV/, assist control ,AC/,  pressure support ventilation /PSV/, proportional assist ventilation/PSV/, pressure control ventilation /PCV/, constant flow ventilation /CFV/|Main points: 1. Interaction between the ventilator and the child; 2. How to achieve synchronization; 3. SIMV; 4. AC; 5. Alternative ventilation;6. PTV – a/ advantages; b/ restrictions in use|Power Point Presentation|lecture presentation,book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.|For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|Educational process in medical study – advanced knowledge acquirement|Expected results – acquiring theoretical knowledge and practical skills for managing ventilation/oxygenation therapy in neonates and children, decision making in NICU  and  PICU|Examination, tests, clinical cases|Anatomy, Physiology, Pathophysiology of gas exchange, Phisics of gases and fluids,Pathoanatomy, Pathophysiology of lung disturbances and diseases, morphofunctional features of neonates and children||different language,different technology|Power Point Presentation
Dora Edreva|CONVENTIONAL VENTILATION - CV|http://moodle-pld.co.cc/file.php/3/52-61.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-05|||||lecture presentation,book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists||For self-preparation, lectures, practical training, seminars for postgraduates, PhD, postdoc students|||||VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter5,|different technology,different language|
Dora Edreva|Continuous Positive Airway Pressure - СРАР|http://moodle-pld.co.cc/file.php/3/49-51.ppt|||ISBN 954-9806-38-3||English|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv|2010-08-23||Ventilation/oxygenation therapy; neonatal, paediatric, intensive care; medical, monitoring and life-support equipment; non-invasive, invasive methods, continuous positive airway pressure /CPAP/barotruma, alveolar collapse|Main points: 1. Implementation of CPAP, 2. Advantages of CPAP; 3.Timing of CPAP; 4. CPAP monitoring|Power Point Presentation|lecture presentation,book|Medicine|Neonatology, Paediatrics, Intensive  Care|PhD – students, MD, anaesthesiologists, paediatricians, intensivists|Educational material for PhD- students, MD, anaesthesiologists,paediatricians, intensivists.||||||VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter4,http://metamorphosis.med.duth.gr/pg/profile/VENTILATION_OXYGENATION_THERAPY_IN_CHILDHOOD_Chapter4|different language,different technology|
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter 11 12|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter11_12.pdf|||||Bulgarian||Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv||||||||||||||||||
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter10|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter10.pdf|||||Bulgarian||Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv||||||||||||||||||
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter9|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter9.pdf|||||Bulgarian|Bulgarian|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv||||||||||||||||||
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter8|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter8.pdf|||||Bulgarian||Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv||||||||||||||||||
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter5|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter7.pdf|||||Bulgarian|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv||||||||||||||||||
Dora Edreva|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter6.pdf||||||Bulgarian|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv||||||||||||||||||
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter5|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter5.pdf|||||Bulgarian|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv||||||||||||||||||
Dora Edreva|VENTILATION OXYGENATION THERAPY IN CHILDHOOD Chapter4|http://moodle-pld.co.cc/file.php/3/Ventilation_Chapter4.pdf|||||Bulgarian|English|Assoc. Prof. L. Despotova-Toleva, MD, PhD, Medical University Plovdiv||||||book||||||||||||
Eva Mihajlova|Лекция №6. ЗАБОЛЯВАНИЯ НА НАДБЪБРЕЧНАТА КОРА. Първична надбъбречнокорова недостатъчност. Вродена надбъбречнокорова хиперплазия|http://moodle-pld.co.cc/file.php/5/hypocorticism-lecture-project.ppt|||Раздел Ендокринология в Учебник за студенти: Клиника и Терапия на Вътрешните болести, 2006 г.||Bulgarian|Bulgarian|Доц. Мария Миткова Орбецова, Началник Клиника по Ендокринология, УМБАЛ „Св. Георги”, Пловдив|2009-12-20||Медицина – ендокринология – студенти – надбъбречна кора – стероидегонеза – първичен хипокортицизъм – болест на Адисон – вродена надбъбречно-корова хиперплазия|Лекцията е част от лекционен курс по ендокринология, покриващ основните ендокринологични заболявания, разпределени по отделни жлези.  Материалът е представен като системно класическо описание на нозологичните единици, отговарящо на изискванията за учебно помагало. 
Лекцията разяснява анатомо-физиологични аспекти на надбъбречните жлези, в частност надбъбречната кора и произвежданите от нея хормони с основните им физиологични действия. В детайли е представена етиопатогенетичната класификация на хипокортицизма. Описана е болестта на Адисон със снимкови и схематични илюстрации. Представени са отделни форми и усложнения на заболяването, методи на диагноза, диференциална диагноза и провеждане на заместително лечение. Във втората част на лекцията е представена регулацията на стероидогенезата и формите на вродена надбъбречнокорова хиперплазия. Описани са основните ензимни дефекти, начини за диагностициранеи лечение.||lecture presentation|||Ниво: висше образование: медицина •	5 курс|•	Целева група – студенти от по медицина, изучаващи модул ендокринология в рамките на обучение по вътрешни болести. За България – студенти от V медицински курс. Възраст между 23 и 25 г. Социо-културен профил – хетерогенен, предимно от семейства на интелектуалци. Български език – нативен или изучаем. Ниво на обучението – І ниво за студенти. Цели на лекционния курс – да се овладеят основни понятия (терминологично и смислово) в ендокринологията; да се добие представа за основни принципи на регулация на хормоналната синтеза, механизъм на действие на отделните хормони; да се добият познания за същност, етиология, патогенеза, класификация, клинична картина, диагноза, диференциална диагноза, лечение на основни ендокринни заболявания; да се създадат умения за разпознаване на специфични симптомокомплекси, насочващи към ендокринна патология, практически подходи към пациентите, суспектни за носителство на ендокринни заболявания. •	Учебният ресурс използва формата на  Лекция / презентация: в класически университетски смисъл, но в електронна форма||Образователни цели:-	преподаване на нови знания / умения-	усвояване и прилагане в практиката на новите знания от страна на обучаемите-	овладяване на умения от обучаемите за разпознаване и лечение в общ план на отделните нозологични единици, разгледани в лекционния курс. -	За Лекция №6– Познания относно структурата на надбъбречната кора, стероидогенезата и нейната регулация; основни действия на надбъбречнокоровите хормони. Представени са причините на хипокортицизъм с отелните му форми. Подробно е описан първичният хроничен хипокортицизъм (болестта на Адисон). Разяснени са методите на диагноза и диференциална диагноза на хипокортицизма, подробна клинична картина,  усложнения, лечение. Дадено е описание на най-честите ензимни дефекти, водещи до вродена надбъбречно-корова хиперплазия, начини за разграничаване и лечение.|Очаквани резултати от обучението:-	усвояване на знания -	овладяване на умения Прицелни умения-	рецептивни –четене с разбиране-	социокултурни (самообучение)-	автономност на обучаемия||Предварително ниво на знания и умения, които обучаемите трябва да притежават, за да ползват учебния ресурс – паралелен курс практически упражнения по ендокринология|||
Eva Mihajlova||http://moodle-pld.co.cc/file.php/5/diabet-lecture-project.ppt|||Раздел Ендокринология в Учебник за студенти: Клиника и Терапия на Вътрешните болести, 2006 г.||Bulgarian|Bulgarian|Доц. Мария Миткова Орбецова, Началник Клиника по Ендокринология, УМБАЛ „Св. Георги”, Пловдив|2009-12-20||Медицина – ендокринология – студенти – захарен диабет  – нарушена гликемия на гладно – намален глюкозен толеранс – гликемичен контрол – хипогликемия – кетоацидоза – хиперосмоларна некетогенна кома – диабетна микроангиопатия – диабетна макроангиопатия – диабетна полиневропатия – диабетна ретинопатия – диабетна нефропатия – диабетно стъпало – перорални антидиабетни средства – инсулин – инсулинови аналози – инкретинови миметици|Лекцията е част от лекционен курс по ендокринология, покриващ основните ендокринологични заболявания, разпределени по отделни жлези.  Материалът е представен като системно класическо описание на нозологичните единици, отговарящо на изискванията за учебно помагало. 
Лекцията разяснява дефиницията, класификацията, характеристиката на отделните форми на захарен диабет с тяхната етиология, патогенеза и клинична картина. Обяснени са  принципите на диагноза на изявения захарен диабет и предиабетните състояния, критериите за скрининг и проследяване. Подробно е застъпено лечението на диабета – обучение, диетичен и физичедски режим, перорални антидиабетни средства с механизъм на действие и странични ефекти; принципите на инсулинолечение, приложението на инсулинови аналози и инкретин-базирана терапия.  Във втората част на лекцията са представени подробно острите (хипогликемия, кетоацидоза, некетогенна хиперосмоларна кома) и хроничните (диабетна микро-, макроангиопатия, диабетна полиневропатия) усложнения с начини на диагноза и лечение. Представено е и необходимото съпътстващо и симптоматично лечение при захарен диабет. Лекционният материал е онагледен със снимкови и схематични илюстрации||lecture presentation,image,diagram,figure|||Ниво: висше образование: медицина •	5 курс|•	Целева група – студенти от по медицина, изучаващи модул ендокринология в рамките на обучение по вътрешни болести. За България – студенти от V медицински курс. Възраст между 23 и 25 г. Социо-културен профил – хетерогенен, предимно от семейства на интелектуалци. Български език – нативен или изучаем. Ниво на обучението – І ниво за студенти. Цели на лекционния курс – да се овладеят основни понятия (терминологично и смислово) в ендокринологията; да се добие представа за основни принципи на регулация на хормоналната синтеза, механизъм на действие на отделните хормони; да се добият познания за същност, етиология, патогенеза, класификация, клинична картина, диагноза, диференциална диагноза, лечение на основни ендокринни заболявания; да се създадат умения за разпознаване на специфични симптомокомплекси, насочващи към ендокринна патология, практически подходи към пациентите, суспектни за носителство на ендокринни заболявания. •	Учебният ресурс използва формата на  Лекция / презентация: в класически университетски смисъл, но в електронна форма||Образователни цели:-	преподаване на нови знания / умения-	усвояване и прилагане в практиката на новите знания от страна на обучаемите-	овладяване на умения от обучаемите за разпознаване и лечение в общ план на отделните нозологични единици, разгледани в лекционния курс. -	За Лекция №10– Познания относно същността, етиопатогенезата на захарния диабет, класификацията и характеристиката на основните типове диабет според СЗО. Разгледани са подробно клиничната картина и  усложненията – остри и хронични (късен дегенеративен исндром. Разяснени са методите на диагноза, скрининг и проследяване на гликемичния контрол и общия контрол на заболяването. Поддробно е разгледано комплексното лечение на захарния диабет с всички негови елементи.|Очаквани резултати от обучението:-	усвояване на знания -	овладяване на умения Прицелни умения-	рецептивни –четене с разбиране-	социокултурни (самообучение)-	автономност на обучаемия|||||
Eva Mihajlova|Лекция №9. ЗАБОЛЯВАНИЯ НА НАДБЪБРЕЧНАТА  МЕДУЛА. Феохромоцитом. МЕН.|http://moodle-pld.co.cc/file.php/5/Pheo-MEN-lecture-project.pdf|||Раздел Ендокринология в Учебник за студенти: Клиника и Терапия на Вътрешните болести, 2006 г.||Bulgarian|Bulgarian|Доц. Мария Миткова Орбецова, Началник Клиника по Ендокринология, УМБАЛ „Св. Георги”, Пловдив|2009-12-20||Медицина – ендокринология – студенти – надбъбречна медула – катехоламини – ендокринна хипертония – феохромоцитом – множествена ендокринна неоплазия|Лекцията е част от лекционен курс по ендокринология, покриващ основните ендокринологични заболявания, разпределени по отделни жлези.  Материалът е представен като системно класическо описание на нозологичните единици, отговарящо на изискванията за учебно помагало. 
Лекцията разяснява накратко анатомо-физиологични аспекти на надбъбречната медула и произвежданите от нея хормони (катехоламини) с основните им физиологични действия. В детайли са представени етиология, патогенеза, клиничната картина и усложненията на феохромоцитома. Разяснени са методите на диагноза, диференциална диагноза и лечение – медикаментозно и радикално (оперативно). Лекционният материал е онагледен със снимкови и схематични илюстрации. Във втората част на лекцията е представена характеристиката на множествената ендокринна неоплазия с основни понятия и представяне на отделните типове МЕН.||lecture notes,lecture presentation,image|||Ниво: висше образование: медицина •	5 курс|•	Целева група – студенти от по медицина, изучаващи модул ендокринология в рамките на обучение по вътрешни болести. За България – студенти от V медицински курс. Възраст между 23 и 25 г. Социо-културен профил – хетерогенен, предимно от семейства на интелектуалци. Български език – нативен или изучаем. Ниво на обучението – І ниво за студенти. Цели на лекционния курс – да се овладеят основни понятия (терминологично и смислово) в ендокринологията; да се добие представа за основни принципи на регулация на хормоналната синтеза, механизъм на действие на отделните хормони; да се добият познания за същност, етиология, патогенеза, класификация, клинична картина, диагноза, диференциална диагноза, лечение на основни ендокринни заболявания; да се създадат умения за разпознаване на специфични симптомокомплекси, насочващи към ендокринна патология, практически подходи към пациентите, суспектни за носителство на ендокринни заболявания. •	Учебният ресурс използва формата на  Лекция / презентация: в класически университетски смисъл, но в електронна форма||Образователни цели:-	преподаване на нови знания / умения-	усвояване и прилагане в практиката на новите знания от страна на обучаемите-	овладяване на умения от обучаемите за разпознаване и лечение в общ план на отделните нозологични единици, разгледани в лекционния курс. -	За Лекция №9– Познания относно структурата на надбъбречната медула, синтеза, секреция, метаболизъм и основни действия на на катехоламините, регулация на секрецията им. Разгледан е подробно феохромоцитомът с отделните му класически и по-редки прояви и форми. Разяснени са методите на диагноза и диференциална диагноза на хипертонията при феохромоцитом, разяснени са принципите и методите на лечение. Обяснена е същността на множествената ендокринна неоплазия и са описани отделните форми на заболяването с кратка характеристика и съпоставка между тях.|Очаквани резултати от обучението:-	усвояване на знания -	овладяване на умения Прицелни умения-	рецептивни –четене с разбиране-	социокултурни (самообучение)-	автономност на обучаемия||Предварително ниво на знания и умения, които обучаемите трябва да притежават, за да ползват учебния ресурс – паралелен курс практически упражнения по ендокринология|||
Eva Mihajlova|Лекция №8. ЗАБОЛЯВАНИЯ НА НАДБЪБРЕЧНАТА КОРА. хипералдостеронизъм|http://moodle-pld.co.cc/file.php/5/hyperaldosteronism-lecture-project.ppt|||За база е използван написаният от автора на лекционния курс Раздел Ендокринология в Учебник за студенти: Клиника и Терапия на Вътрешните болести, 2006||Bulgarian|Bulgarian|Доц. Мария Миткова Орбецова, Началник Клиника по Ендокринология, УМБАЛ „Св. Георги”, Пловдив|2009-12-20||Медицина – ендокринология – студенти – надбъбречна кора – минералокортикоиди – ендокринна хипертония -хипералдостеронизъм – синдром на Conn -|Лекцията е част от лекционен курс по ендокринология, покриващ основните ендокринологични заболявания, разпределени по отделни жлези.  Материалът е представен като системно класическо описание на нозологичните единици, отговарящо на изискванията за учебно помагало. 
Лекцията разяснява накратко анатомо-физиологични аспекти на надбъбречните жлези, в частност надбъбречната кора и произвежданите от нея хормони с основните им физиологични действия. Акцентът е върху минералокортикоидната обмяна. В детайли е представена етиопатогенетичната класификация на хипералдостеронизма. Описани са отделните форми на хипералдостеронизъм като клиничната картина и усложненията са подробно представени. Разяснени са методите на диагноза, диференциална диагноза и лечение – медикаментозно и радикално (оперативно).Лекционният материал е онагледен със снимкови и схематични илюстрации.||lecture presentation,image,diagram,figure|||Ниво: висше образование: медицина •	5 курс|•	Целева група – студенти от по медицина, изучаващи модул ендокринология в рамките на обучение по вътрешни болести. За България – студенти от V медицински курс. Възраст между 23 и 25 г. Социо-културен профил – хетерогенен, предимно от семейства на интелектуалци. Български език – нативен или изучаем. Ниво на обучението – І ниво за студенти. Цели на лекционния курс – да се овладеят основни понятия (терминологично и смислово) в ендокринологията; да се добие представа за основни принципи на регулация на хормоналната синтеза, механизъм на действие на отделните хормони; да се добият познания за същност, етиология, патогенеза, класификация, клинична картина, диагноза, диференциална диагноза, лечение на основни ендокринни заболявания; да се създадат умения за разпознаване на специфични симптомокомплекси, насочващи към ендокринна патология, практически подходи към пациентите, суспектни за носителство на ендокринни заболявания. •	Учебният ресурс използва формата на  Лекция / презентация: в класически университетски смисъл, но в електронна форма||Образователни цели:-	преподаване на нови знания / умения-	усвояване и прилагане в практиката на новите знания от страна на обучаемите-	овладяване на умения от обучаемите за разпознаване и лечение в общ план на отделните нозологични единици, разгледани в лекционния курс. -	За Лекция №8– Познания относно структурата на надбъбречната кора, стероидогенезата и нейната регулация; основни действия на надбъбречнокоровите хормони с акцент върху минералокортикоидите с краен представител алдостерон. Представени са причините на хипералдостеронизъм с отделните му форми. Разяснени са методите на диагноза и диференциална диагноза на минералокортикоидната хипертония, представена е подробна характеристика на отделните форми на заболяването, наличните усложнения и методите на лечение. Застъпени са и някои по-редки форми на хиперминералокортицизъм.|Очаквани резултати от обучението:-	усвояване на знания -	овладяване на умения Прицелни умения-	рецептивни –четене с разбиране-	социокултурни (самообучение)-	автономност на обучаемия||Предварително ниво на знания и умения, които обучаемите трябва да притежават, за да ползват учебния ресурс – паралелен курс практически упражнения по ендокринология|||
Eva Mihajlova|Лекция №7. ЗАБОЛЯВАНИЯ НА НАДБЪБРЕЧНАТА КОРА. Синдром на Cushing|http://moodle-pld.co.cc/file.php/5/Cushing-lecture-project.pdf|||||Bulgarian|Bulgarian|Доц. Мария Миткова Орбецова, Началник Клиника по Ендокринология, УМБАЛ „Св. Георги”, Пловдив|2009-12-20||Медицина – ендокринология – студенти – надбъбречна кора – стероидегонеза – хиперкортицизъм – синдром на Cushing|Лекцията е част от лекционен курс по ендокринология, покриващ основните ендокринологични заболявания, разпределени по отделни жлези.  Материалът е представен като системно класическо описание на нозологичните единици, отговарящо на изискванията за учебно помагало. 
Лекцията разяснява накратко анатомо-физиологични аспекти на надбъбречните жлези, в частност надбъбречната кора и произвежданите от нея хормони с основните им физиологични действия. В детайли е представена етиопатогенетичната класификация на синдрома на Cushing – АКТХ-зависим и АКТХ-независим. Описани са отделните форми на хиперкортицизма като клиничната картина и усложненията са подробно представени със снимкови и схематични илюстрации. Разяснени са методите на диагноза, диференциална диагноза и лечение – медикаментозно и радикално (оперативно, лъчелечение).||lecture notes,lecture presentation|||Ниво: висше образование: медицина •	5 курс|ендокринология в рамките на обучение по вътрешни болести. За България – студенти от V медицински курс. Възраст между 23 и 25 г. Социо-културен профил – хетерогенен, предимно от семейства на интелектуалци. Български език – нативен или изучаем. Ниво на обучението – І ниво за студенти. Цели на лекционния курс – да се овладеят основни понятия (терминологично и смислово) в ендокринологията; да се добие представа за основни принципи на регулация на хормоналната синтеза, механизъм на действие на отделните хормони; да се добият познания за същност, етиология, патогенеза, класификация, клинична картина, диагноза, диференциална диагноза, лечение на основни ендокринни заболявания; да се създадат умения за разпознаване на специфични симптомокомплекси, насочващи към ендокринна патология, практически подходи към пациентите, суспектни за носителство на ендокринни заболявания. •	Учебният ресурс използва формата на  Лекция / презентация: в класически университетски смисъл, но в електронна форма|Ресурсът може да се използва чрез преглед на презентацията – еднократно или многократно, в презентация е включен и снимков материал, улесняващ описанието на клиничните симптоми, както и схеми и таблици, подходящи за структурираното обучение.|Образователни цели:-	преподаване на нови знания / умения-	усвояване и прилагане в практиката на новите знания от страна на обучаемите-	овладяване на умения от обучаемите за разпознаване и лечение в общ план на отделните нозологични единици, разгледани в лекционния курс. -	За Лекция №7– Познания относно структурата на надбъбречната кора, стероидогенезата и нейната регулация; основни действия на надбъбречнокоровите хормони. Представени са причините на хиперкортицизъм с отелните му форми. Подробно е описан синдромът на Cushing като общо и тясно понятие.  Разяснени са методите на диагноза и диференциална диагноза на хиперкортицизма, подробна клинична картина,  усложнения, лечение. Дадено е характеристика на някои по-редки форми на синдрома на Cushing|Очаквани резултати от обучението:-	усвояване на знания -	овладяване на умения Прицелни умения-	рецептивни –четене с разбиране-	социокултурни (самообучение)-	автономност на обучаемия||Предварително ниво на знания и умения, които обучаемите трябва да притежават, за да ползват учебния ресурс – паралелен курс практически упражнения по ендокринология|||
Eva Mihajlova|Лекция №5. ЗАБОЛЯВАНИЯ  НА  ПАРАЩИТОВИДНИТЕ ЖЛЕЗИ – регулация на калциево-фосфорната обмяна, хипопаратиреоидизъм; хиперпаратиреоидизъм.|http://moodle-pld.co.cc/file.php/5/Parathyroid-glands-lecture-project.ppt|||||Bulgarian|Bulgarian|Доц. Мария Миткова Орбецова, Началник Клиника по Ендокринология, УМБАЛ „Св. Георги”, Пловдив|2009-12-20||Медицина – ендокринология – студенти – калциево-фосфорна обмяна - паращитовидни жлези – хипопаратиреоидизъм - хиперпаратиреоидизъм|Лекцията е част от лекционен курс по ендокринология, покриващ основните ендокринологични заболявания, разпределени по отделни жлези.  Материалът е представен като системно класическо описание на нозологичните единици, отговарящо на изискванията за учебно помагало. 
Лекцията разяснява основни понятия по отношение регулация на калциево-фосфорната обмяна и действието на паратхормона, калцитонина и Витамин Д. Разгледани са класификацията на хипо- и хиперпаратиреоидизма и основните нозологични единици, с подробно описание на етиология, патогенеза, клинична картина, критерии за диагноза, диференциална диагноза, усложнения, избор на лечебен подход и проследяване||lecture presentation|||Ниво: висше образование: медицина •	5 курс|•	Целева група – студенти от по медицина, изучаващи модул ендокринология в рамките на обучение по вътрешни болести. За България – студенти от V медицински курс. Възраст между 23 и 25 г. Социо-културен профил – хетерогенен, предимно от семейства на интелектуалци. Български език – нативен или изучаем. Ниво на обучението – І ниво за студенти. Цели на лекционния курс – да се овладеят основни понятия (терминологично и смислово) в ендокринологията; да се добие представа за основни принципи на регулация на хормоналната синтеза, механизъм на действие на отделните хормони; да се добият познания за същност, етиология, патогенеза, класификация, клинична картина, диагноза, диференциална диагноза, лечение на основни ендокринни заболявания; да се създадат умения за разпознаване на специфични симптомокомплекси, насочващи към ендокринна патология, практически подходи към пациентите, суспектни за носителство на ендокринни заболявания. •	Учебният ресурс използва формата на  Лекция / презентация: в класически университетски смисъл, но в електронна форма||Образователни цели:-	преподаване на нови знания / умения-	усвояване и прилагане в практиката на новите знания от страна на обучаемите-	овладяване на умения от обучаемите за разпознаване и лечение в общ план на отделните нозологични единици, разгледани в лекционния курс. -	За Лекция №5 – Познания относно регулацията на калциево-фосфорната обмяна,  кратки анатомо-физиологични данни за паращитовидните жлези, описание на заболяванията, водещи до понижена и повишена функция на паращитовидните жлези с класификация, методи на диагноза и диференциална диагноза на хипо- и хиперкалциемиите, подробна клинична картина,  усложнения, лечение.|Очаквани резултати от обучението:-	усвояване на знания -	овладяване на умения Прицелни умения-	рецептивни –четене с разбиране-	социокултурни (самообучение)-	автономност на обучаемия||Предварително ниво на знания и умения, които обучаемите трябва да притежават, за да ползват учебния ресурс – паралелен курс практически упражнения по ендокринология|||
Eva Mihajlova|Лекция №4. ЗАБОЛЯВАНИЯ НА ЩИТОВИДНАТА ЖЛЕЗА Хипертиреоидизъм и тиреотоксикоза. Тиреоидни карциноми|http://moodle-pld.co.cc/file.php/5/hyperthyroid-lecture-project.ppt|||Раздел Ендокринология в Учебник за студенти: Клиника и Терапия на Вътрешните болести, 2006 г.||Bulgarian|Bulgarian|Доц. Мария Миткова Орбецова, Началник Клиника по Ендокринология, УМБАЛ „Св. Георги”, Пловдив|2009-12-20||Медицина – ендокринология – студенти – щитовидна жлеза – тиреотоксикоза – хипертиреоидизъм – Базедова болест – токсичен аденом – нодозна базедовифицирана гуша – тиреоиден карцином|Лекцията е част от лекционен курс по ендокринология, покриващ основните ендокринологични заболявания, разпределени по отделни жлези.  Материалът е представен като системно класическо описание на нозологичните единици, отговарящо на изискванията за учебно помагало. 
Лекцията разяснява основни понятия – тиреотоксикоза и хипертиреоидизъм.  Разгледани са основните нозологични единици, протичащи с хипертиреоидизъм, с подробно описание на клинична картина, критерии за диагноза, диференциална диагноза, усложнения, избор на лечебен подход и проследяване . Дадена е класификация и подробно са представени различните видове тиреоидни карциноми с особености в клиничната картина, най-подходящите методи на диагноза и лечение, подход при следоперативно проследяване и прогноза.||lecture presentation|||Ниво: висше образование: медицина •	5 курс|ендокринология в рамките на обучение по вътрешни болести. За България – студенти от V медицински курс. Възраст между 23 и 25 г. Социо-културен профил – хетерогенен, предимно от семейства на интелектуалци. Български език – нативен или изучаем. Ниво на обучението – І ниво за студенти. Цели на лекционния курс – да се овладеят основни понятия (терминологично и смислово) в ендокринологията; да се добие представа за основни принципи на регулация на хормоналната синтеза, механизъм на действие на отделните хормони; да се добият познания за същност, етиология, патогенеза, класификация, клинична картина, диагноза, диференциална диагноза, лечение на основни ендокринни заболявания; да се създадат умения за разпознаване на специфични симптомокомплекси, насочващи към ендокринна патология, практически подходи към пациентите, суспектни за носителство на ендокринни заболявания. •	Учебният ресурс използва формата на  Лекция / презентация: в класически университетски смисъл, но в електронна форма||Образователни цели:-	преподаване на нови знания / умения-	усвояване и прилагане в практиката на новите знания от страна на обучаемите-	овладяване на умения от обучаемите за разпознаване и лечение в общ план на отделните нозологични единици, разгледани в лекционния курс. -	За Лекция №4 – Познания относно заболяванията на щитовидната жлеза, водещи до повишена функция, класификация на тиреотоксикозата и в частност хипертиреоидизма - описание на Базедова болест, токсичен аденом, нодозна базедовифицирана гуша с подробна клинична картина,  диагноза, усложнения,  лечение на хипертиреоидизма. Втората част на лекцията съдържа данни за разпространение, класификация, диагностициране и лечение на тиреоидните карциноми със съпоставителна характеристика.|Очаквани резултати от обучението:-	усвояване на знания -	овладяване на умения Прицелни умения-	рецептивни –четене с разбиране-	социокултурни (самообучение)-	автономност на обучаемия||Предварително ниво на знания и умения, които обучаемите трябва да притежават, за да ползват учебния ресурс – паралелен курс практически упражнения по ендокринология|||
Eva Mihajlova|Лекция №3. ЗАБОЛЯВАНИЯ НА ЩИТОВИДНАТА ЖЛЕЗА Гуша. Хипотиреоидизъм. Тиреоидити|http://moodle-pld.co.cc/file.php/5/thyroid-goiter-hypo-thyroiditis-project.ppt|||За база е използван написаният от автора на лекционни курс Раздел Ендокринология в Учебник за студенти: Клиника и Терапия на Вътрешните болести, 2006 г.||Bulgarian|Bulgarian|Доц. Мария Миткова Орбецова, Началник Клиника по Ендокринология, УМБАЛ „Св. Георги”, Пловдив|2009-12-20||Медицина – ендокринология – студенти – щитовидна жлеза – гуша – хипотиреоидизъм - тиреоидити|Лекцията е част от лекционен курс по ендокринология, покриващ основните ендокринологични заболявания, разпределени по отделни жлези.  Материалът е представен като системно класическо описание на нозологичните единици, отговарящо на изискванията за учебно помагало. 
Първата част на лекцията съдържа кратки анатомо-физиологични данни за щитовидната жлеза и причините за нейното увеличение; показана е степенната класификация на гушите, разгледани са ендемичната и спорадичната гуши. Разгледани са дефинициите, етиопатогенетичната класификация, клиничната картина, диагнозата и лечението на хипотиреоидизма. Дадена е класификация и подробно са представени различните видове тиреоидити||lecture presentation|||Ниво: висше образование: медицина •	5 курс|•	Целева група – студенти от по медицина, изучаващи модул ендокринология в рамките на обучение по вътрешни болести. За България – студенти от V медицински курс. Възраст между 23 и 25 г. Социо-културен профил – хетерогенен, предимно от семейства на интелектуалци. Български език – нативен или изучаем. Ниво на обучението – І ниво за студенти. Цели на лекционния курс – да се овладеят основни понятия (терминологично и смислово) в ендокринологията; да се добие представа за основни принципи на регулация на хормоналната синтеза, механизъм на действие на отделните хормони; да се добият познания за същност, етиология, патогенеза, класификация, клинична картина, диагноза, диференциална диагноза, лечение на основни ендокринни заболявания; да се създадат умения за разпознаване на специфични симптомокомплекси, насочващи към ендокринна патология, практически подходи към пациентите, суспектни за носителство на ендокринни заболявания. •	Учебният ресурс използва формата на  Лекция / презентация: в класически университетски смисъл, но в електронна форма||Образователни цели:-	преподаване на нови знания / умения-	усвояване и прилагане в практиката на новите знания от страна на обучаемите-	овладяване на умения от обучаемите за разпознаване и лечение в общ план на отделните нозологични единици, разгледани в лекционния курс. -	За Лекция №3 – Познания относно заболяванията на щитовидната жлеза - описание на различните видове гуши – ендемична и спорадична; дифузни и нодозни гуши; класификация, подробна клинична картина,  диагноза, усложнения,  лечение на хипотиреоидизма; разпознаване, диагностициране, лечение на тиреоидитите – по-подробно обяснение и сравнителна характеристика на най-честите форми|Очаквани резултати от обучението:-	усвояване на знания -	овладяване на умения Прицелни умения-	рецептивни –четене с разбиране-	социокултурни (самообучение)-	автономност на обучаемия|||||
Eva Mihajlova|Лекция №2. ХИПОПИТУИТАРИЗЪМ. ЗАБОЛЯВАНИЯ НА НЕВРОХИПОФИЗАТА Инсипиден диабет. SIADH|http://moodle-pld.co.cc/file.php/5/Hypopituitar-Diabinsip-lecture-project.ppt|||||Bulgarian|Bulgarian|Доц. Мария Миткова Орбецова, Началник Клиника по Ендокринология, УМБАЛ „Св. Георги”, Пловдив|2009-12-20||Медицина – ендокринология – студенти – хипопитуитаризъм -неврохипофиза – инсипиден диабет – синдром на несъответна секреция на антидиуретичен хормон|Лекцията е част от лекционен курс по ендокринология, покриващ основните ендокринологични заболявания, разпределени по отделни жлези.  Материалът е представен като системно класическо описание на нозологичните единици, отговарящо на изискванията за учебно помагало. 
Първата част на лекцията съдържа данни за класификация, клинична картина, диагноза, диференциална диагноза и лечение на хипопитуитаризма. Отделя се място на синдрома на  Simonds-Sheehan. Втората част включва кратки данни за анатомия и физиология на неврохипофизата, описание на неврохипофизарните хормони, връзката с хипоталамуса; видовете заболявания на неврохипофизата. Подробно е разгледан инсипидният диабет с типовите параграфи за лекционния курс: определение, етиология, патогенеза, клинична картина, усложнения, тестове и методи на диагноза, диференциална диагноза, лечение. Характеризиран е в резюме синдромът на несъответна секреция на АДХ, който е рядко заболяване, но трябва да се познава.||lecture presentation|||Ниво: висше образование: медицина •	5 курс|•	Целева група – студенти от по медицина, изучаващи модул ендокринология в рамките на обучение по вътрешни болести. За България – студенти от V медицински курс. Възраст между 23 и 25 г. Социо-културен профил – хетерогенен, предимно от семейства на интелектуалци. Български език – нативен или изучаем. Ниво на обучението – І ниво за студенти. Цели на лекционния курс – да се овладеят основни понятия (терминологично и смислово) в ендокринологията; да се добие представа за основни принципи на регулация на хормоналната синтеза, механизъм на действие на отделните хормони; да се добият познания за същност, етиология, патогенеза, класификация, клинична картина, диагноза, диференциална диагноза, лечение на основни ендокринни заболявания; да се създадат умения за разпознаване на специфични симптомокомплекси, насочващи към ендокринна патология, практически подходи към пациентите, суспектни за носителство на ендокринни заболявания. •	Учебният ресурс използва формата на  Лекция / презентация: в класически университетски смисъл, но в електронна форма||Образователни цели:-	преподаване на нови знания / умения-	усвояване и прилагане в практиката на новите знания от страна на обучаемите-	овладяване на умения от обучаемите за разпознаване и лечение в общ план на отделните нозологични единици, разгледани в лекционния курс. -	За Лекция №2 – разпознаване, диагностициране, лечение на хипопитуитаризма – по-подробно обяснение на най-честите му форми – постоперативен/пострадиационен и следродова некроза на хипофизата (синдром на Simmonds-Sheehan). Познания относно заболяванията на неврохипофизата, по-специално инсипидния диабет с различните му форми – централен, нефрогенен, дипсогенен, клинична картина, усложнения, диференциална диагноза, лечение. Общи познания върху синдрома на несъответна секреция на АДХ|Очаквани резултати от обучението:-	усвояване на знания -	овладяване на умения Прицелни умения-	рецептивни –четене с разбиране-	социокултурни (самообучение)-	автономност на обучаемия||Предварително ниво на знания и умения, които обучаемите трябва да притежават, за да ползват учебния ресурс – паралелен курс практически упражнения по ендокринология|||
Eva Mihajlova|Лекция №1. БОЛЕСТИ НА АДЕНОХИПОФИЗАТА. Аденоми. Пролактином. Акромегалия|http://moodle-pld.co.cc/file.php/5/adenohypophysis-lecture-project.pdf|||||||Доц. Мария Миткова Орбецова, Началник Клиника по Ендокринология, УМБАЛ „Св. Георги”, Пловдив|2009-12-20||Медицина – ендокринология – студенти – аденоми на хипофиза – пролактином - акромегалия|Лекцията е част от лекционен курс по ендокринология, покриващ основните ендокринологични заболявания, разпределени по отделни жлези.  Материалът е представен като системно класическо описание на нозологичните единици, отговарящо на изискванията за учебно помагало. 
Включва кратки данни за анатомия и физиология на хипофизата, описание на аденохипофизарните клетки и тяхната секреция, връзката с хипоталамуса; видове заболявания на аденохипофизата. Подробно са разгледани пролактиномът и акромегалията. И за двете нозологични единици са представени етиология, патогенеза, клинична картина, усложнения, тестове и методи на диагноза, диференциална диагноза, лечение. При пролактиномите са представени разликите между мъжки и женски пол, обърнато е внимание на отдиференциране на други причини за хиперпролактинемия извън пролактином. При акромегалията са представени и снимки на характерни клинични белези, което улеснява възприемането на лекционния материал.||lecture notes|Медицина|Ендокринология|Ниво: висше образование: медицина •	5 курс|•	Целева група – студенти от по медицина, изучаващи модул ендокринология в рамките на обучение по вътрешни болести. За България – студенти от V медицински курс. Възраст между 23 и 25 г. Социо-културен профил – хетерогенен, предимно от семейства на интелектуалци. Български език – нативен или изучаем. Ниво на обучението – І ниво за студенти. Цели на лекционния курс – да се овладеят основни понятия (терминологично и смислово) в ендокринологията; да се добие представа за основни принципи на регулация на хормоналната синтеза, механизъм на действие на отделните хормони; да се добият познания за същност, етиология, патогенеза, класификация, клинична картина, диагноза, диференциална диагноза, лечение на основни ендокринни заболявания; да се създадат умения за разпознаване на специфични симптомокомплекси, насочващи към ендокринна патология, практически подходи към пациентите, суспектни за носителство на ендокринни заболявания. •	Учебният ресурс използва формата на  Лекция / презентация: в класически университетски смисъл, но в електронна форма|Ресурсът може да се използва чрез преглед на презентацията – еднократно или многократно, в презентация е включен и снимков материал, улесняващ описанието на клиничните симптоми, както и схеми и таблици, подходящи за структурираното обучение.|Образователни цели:-	преподаване на нови знания / умения-	усвояване и прилагане в практиката на новите знания от страна на обучаемите-	овладяване на умения от обучаемите за разпознаване и лечение в общ план на отделните нозологични единици, разгледани в лекционния курс. -	За Лекция №1 – разпознаване, диагностициране, лечение на болестите на аденохипофизата, в частност на пролактиноми и акромегалия. Познания относно клинична картина, усложнения, диференциална диагноза|Очаквани резултати от обучението:-	усвояване на знания -	овладяване на умения Прицелни умения-	рецептивни –четене с разбиране-	социокултурни (самообучение)-	автономност на обучаемия||Предварително ниво на знания и умения, които обучаемите трябва да притежават, за да ползват учебния ресурс – паралелен курс практически упражнения по ендокринология|||
Philip Davies|Вакцинация против ВПЧ и рака шейки|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Russian|English|European Cervical Cancer Association|2010-03-19||Вакцинация, ВПЧ, рака шейки|This resource contains text and illustrations presenting a summary of a) the risk of cervical cancer, b) the role of the HPV in cervical carcinogenesis, c) the mechanism of action of the HPV vaccines, d) the role of the HPV vaccines in reducing the risk of cervical cancer and e) the recommendations for the use of the HPV vaccines in Russia. It is intended to support healthcare providers in the region to educate their patients about cervical cancer screening.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the protection afforded by the HPV vaccines and the recommendations for their use to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What causes cervical cancer2. How HPV vaccination works to prevent cervical cancer3. The benefits and limitations of HPV vaccination4. Who should be vaccinated5. How long vaccination protect lasts6. If boys or men be vaccinated7. Vaccination safety|1. Better understanding of the benefits and drawbacks of HPV vaccination2. Better understanding of the appropriate target populations for HPV vaccination3. Better understanding of the regional recommendations for HPV vaccination|1. Physician feedback2. Uptake of adolescent HPV vaccination among the clinic’s patients|None|||
Philip Davies|Тактика при аномалиях в Пап тесте : наблюдение или лечение?|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Russian|English|European Cervical Cancer Association|2010-03-19||аномалиях в Пап тесте|This resource contains text and illustrations presenting a summary of a) the different non-negative Pap smear results and b) the clinical procedures that are used to follow-up each non-negative result in Russia. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the possible results and clinical procedures that may follow a Pap smear to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What non-normal cervical smear results are possible2. What happens next for each possible non-normal result3. What a colposcopy is4. What a biopsy is5. What happens after a biopsy6. What are the possible treatments7. What happens after each treatment|1. Better understanding of the possible Pap smear results2. Better understanding of clinical steps that will be recommended to follow-up each non-negative Pap smear result3. Reduced fear of follow-up and increased compliance with follow-up recommendations|1. Physician feedback2. Follow-up compliance among the clinic's patients|None|||
Philip Davies|Вирус папилломы человека (ВПЧ ) и рак шейки матки|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Russian|English|European Cervical Cancer Association|2010-03-19||Вирус папилломы человека, ВПЧ, рак шейки матки|This resource contains text and illustrations presenting a summary of role of the Human papillomavirus (HPV) in cervical carcinogenesis. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cause of cervical cancer to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What causes cervical cancer2. How do you catch genital HPV3. How can you protect yourself4. Can genital HPV be treated5. Will HPV affect pregnancy6. What is HPV testing|1. Better understanding of the role of HPV in cervical carcinogenesis2. Better understanding of the natural history of HPV infection3. Better understanding of the benefits and limitations of HPV testing|1. Physician feedback|None|||
Philip Davies|Скрининг на рак шейки матки|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Russian|English|European Cervical Cancer Association|2010-03-19||Скрининг, рак шейки матки|This resource contains text and illustrations presenting a summary of a) the risk of cervical cancer, b) the role of screening in reducing this risk, c) the screening recommendations and d) the screening process as conducted in Russia. It is intended to support healthcare providers in the region to educate their patients about cervical cancer screening.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cervical cancer screening process to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. Their risk for developing cervical cancer2. That cervical cancer screening can reduce cervical cancer rates by 80% but that regular screening is essential to maximise the protection3. How often they should be screened to obtain the maximum protection4. What happens during the screening appointment5. How to make a screening appointment|1. Better understanding of the risk of cervical cancer2. Better understanding of the steps that can be taken to reduce the risk of cervical cancer3. Increased uptake of cervical cancer screening|1. Physician feedback2. Uptake of cervical cancer screening among the clinic's patients|None|||
Philip Davies|Vaccinarea impotriva HPV si a cancerului de col uterin|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Romanian|English|European Cervical Cancer Association|2009-11-20||Vaccinarea, HPV, cancerului de col uterin|This resource contains text and illustrations presenting a summary of a) the risk of cervical cancer, b) the role of the HPV in cervical carcinogenesis, c) the mechanism of action of the HPV vaccines, d) the role of the HPV vaccines in reducing the risk of cervical cancer and e) the recommendations for the use of the HPV vaccines in Romania. It is intended to support healthcare providers in the region to educate their patients about cervical cancer screening.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the protection afforded by the HPV vaccines and the recommendations for their use to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What causes cervical cancer2. How HPV vaccination works to prevent cervical cancer3. The benefits and limitations of HPV vaccination4. Who should be vaccinated5. How long vaccination protect lasts6. If boys or men be vaccinated7. Vaccination safety|1. Better understanding of the benefits and drawbacks of HPV vaccination2. Better understanding of the appropriate target populations for HPV vaccination3. Better understanding of the regional recommendations for HPV vaccination|1. Physician feedback2. Uptake of adolescent HPV vaccination among the clinic’s patients|None|||
Philip Davies|Urmarirea si tratamentul dupa un test Papanicolau anormal|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Romanian|English|European Cervical Cancer Association|2009-11-20||Urmarirea, tratamentul, test Papanicolau anormal|This resource contains text and illustrations presenting a summary of a) the different non-negative Pap smear results and b) the clinical procedures that are used to follow-up each non-negative result in Romania. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the possible results and clinical procedures that may follow a Pap smear to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What non-normal cervical smear results are possible2. What happens next for each possible non-normal result3. What a colposcopy is4. What a biopsy is5. What happens after a biopsy6. What are the possible treatments7. What happens after each treatment|1. Better understanding of the possible Pap smear results2. Better understanding of clinical steps that will be recommended to follow-up each non-negative Pap smear result3. Reduced fear of follow-up and increased compliance with follow-up recommendations|1. Physician feedback2. Follow-up compliance among the clinic's patients|None|||
Philip Davies|Virusul Papilloma si cancerul de col uterin|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Romanian|English|European Cervical Cancer Association|2009-11-20||Virusul Papilloma, HPV, cancerul de col uterin|This resource contains text and illustrations presenting a summary of role of the Human papillomavirus (HPV) in cervical carcinogenesis. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cause of cervical cancer to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What causes cervical cancer2. How do you catch genital HPV3. How can you protect yourself4. Can genital HPV be treated5. Will HPV affect pregnancy6. What is HPV testing|1. Better understanding of the role of HPV in cervical carcinogenesis2. Better understanding of the natural history of HPV infection3. Better understanding of the benefits and limitations of HPV testing|1. Physician feedback|None|||
Philip Davies|Screening-ul cancerului de col uterin|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Romanian|English|European Cervical Cancer Association|2009-11-20||Screening-ul, cancerului de col uterin|This resource contains text and illustrations presenting a summary of a) the risk of cervical cancer, b) the role of screening in reducing this risk, c) the screening recommendations and d) the screening process as conducted in Romania. It is intended to support healthcare providers in the region to educate their patients about cervical cancer screening.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cervical cancer screening process to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. Their risk for developing cervical cancer2. That cervical cancer screening can reduce cervical cancer rates by 80% but that regular screening is essential to maximise the protection3. How often they should be screened to obtain the maximum protection4. What happens during the screening appointment5. How to make a screening appointment|1. Better understanding of the risk of cervical cancer2. Better understanding of the steps that can be taken to reduce the risk of cervical cancer3. Increased uptake of cervical cancer screening|1. Physician feedback2. Uptake of cervical cancer screening among the clinic's patients|None|||
Philip Davies|Kontrola i leczenie pacjentek z nieprawidłowym wynikiem badania cytologicznego|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Polish|English|European Cervical Cancer Association|2010-03-10||Kontrola, leczenie, nieprawidłowym wynikiem badania cytologicznego|This resource contains text and illustrations presenting a summary of a) the different non-negative Pap smear results and b) the clinical procedures that are used to follow-up each non-negative result in Poland. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the possible results and clinical procedures that may follow a Pap smear to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What non-normal cervical smear results are possible2. What happens next for each possible non-normal result3. What a colposcopy is4. What a biopsy is5. What happens after a biopsy6. What are the possible treatments7. What happens after each treatment|1. Better understanding of the possible Pap smear results2. Better understanding of clinical steps that will be recommended to follow-up each non-negative Pap smear result3. Reduced fear of follow-up and increased compliance with follow-up recommendations.|1. Physician feedback2. Follow-up compliance among the clinic's patients|None|||
Philip Davies|Wirus brodawczaka ludzkiego a rak szyjki macicy|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Polish|English|European Cervical Cancer Association|2010-03-10||Wirus brodawczaka ludzkiego, raka szyjki macicy|This resource contains text and illustrations presenting a summary of role of the Human papillomavirus (HPV) in cervical carcinogenesis. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cause of cervical cancer to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What causes cervical cancer2. How do you catch genital HPV3. How can you protect yourself4. Can genital HPV be treated5. Will HPV affect pregnancy6. What is HPV testing|1. Better understanding of the role of HPV in cervical carcinogenesis2. Better understanding of the natural history of HPV infection3. Better understanding of the benefits and limitations of HPV testing|1. Better understanding of the role of HPV in cervical carcinogenesis2. Better understanding of the natural history of HPV infection3. Better understanding of the benefits and limitations of HPV testing|None|||
Philip Davies|Skryning raka szyjki macicy|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Polish|English|European Cervical Cancer Association|2010-03-10||Skryning, raka szyjki macicy|This resource contains text and illustrations presenting a summary of a) the risk of cervical cancer, b) the role of screening in reducing this risk, c) the screening recommendations and d) the screening process as conducted in Poland. It is intended to support healthcare providers in the region to educate their patients about cervical cancer screening.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cervical cancer screening process to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. Their risk for developing cervical cancer2. That cervical cancer screening can reduce cervical cancer rates by 80% but that regular screening is essential to maximise the protection3. How often they should be screened to obtain the maximum protection4. What happens during the screening appointment5. How to make a screening appointment|1. Better understanding of the risk of cervical cancer2. Better understanding of the steps that can be taken to reduce the risk of cervical cancer3. Increased uptake of cervical cancer screening|1. Physician feedback2. Uptake of cervical cancer screening among the clinic's patients|None|||
Philip Davies|Vacinação contra o HPV e cancro do colo do útero|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Portuguese|English|European Cervical Cancer Association|2009-12-08||Vacinação, HPV, cancro do colo do útero|This resource contains text and illustrations presenting a summary of a) the risk of cervical cancer, b) the role of the HPV in cervical carcinogenesis, c) the mechanism of action of the HPV vaccines, d) the role of the HPV vaccines in reducing the risk of cervical cancer and e) the recommendations for the use of the HPV vaccines in Portugal. It is intended to support healthcare providers in the region to educate their patients about cervical cancer screening.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the protection afforded by the HPV vaccines and the recommendations for their use to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What causes cervical cancer2. How HPV vaccination works to prevent cervical cancer3. The benefits and limitations of HPV vaccination4. Who should be vaccinated5. How long vaccination protect lasts6. If boys or men be vaccinated7. Vaccination safety|1. Better understanding of the benefits and drawbacks of HPV vaccination2. Better understanding of the appropriate target populations for HPV vaccination3. Better understanding of the regional recommendations for HPV vaccination|1. Physician feedback2. Uptake of adolescent HPV vaccination among the clinic’s patients|None|||
Philip Davies|Seguimento e tratamento de um exame de Papanicolaou anormal|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Portuguese|English|European Cervical Cancer Association|2009-12-08||Seguimento, tratamento, Papanicolaou anormal|This resource contains text and illustrations presenting a summary of a) the different non-negative Pap smear results and b) the clinical procedures that are used to follow-up each non-negative result in Portugal. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the possible results and clinical procedures that may follow a Pap smear to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What non-normal cervical smear results are possible2. What happens next for each possible non-normal result3. What a colposcopy is4. What a biopsy is5. What happens after a biopsy6. What are the possible treatments7. What happens after each treatment|1. Better understanding of the possible Pap smear results2. Better understanding of clinical steps that will be recommended to follow-up each non-negative Pap smear result3. Reduced fear of follow-up and increased compliance with follow-up recommendations|1. Physician feedback2. Follow-up compliance among the clinic's patients|None|||
Philip Davies|O Vírus do Papiloma Humano (HPV) e o cancro do colo do útero|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Portuguese|English|European Cervical Cancer Association|2009-12-08||Vírus do Papiloma Humano, HPV, cancro do colo do útero|This resource contains text and illustrations presenting a summary of role of the Human papillomavirus (HPV) in cervical carcinogenesis. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cause of cervical cancer to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What causes cervical cancer2. How do you catch genital HPV3. How can you protect yourself4. Can genital HPV be treated5. Will HPV affect pregnancy6. What is HPV testing|1. Better understanding of the role of HPV in cervical carcinogenesis2. Better understanding of the natural history of HPV infection3. Better understanding of the benefits and limitations of HPV testing|1. Physician feedback|None|||
Philip Davies|Rastreio do Cancro do Colo do Útero|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Portuguese|English|European Cervical Cancer Association|2009-12-08||Rastreio, cancro do colo do utero|This resource contains text and illustrations presenting a summary of a) the risk of cervical cancer, b) the role of screening in reducing this risk, c) the screening recommendations and d) the screening process as conducted in Portugal. It is intended to support healthcare providers in the region to educate their patients about cervical cancer screening.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cervical cancer screening process to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. Their risk for developing cervical cancer2. That cervical cancer screening can reduce cervical cancer rates by 80% but that regular screening is essential to maximise the protection3. How often they should be screened to obtain the maximum protection4. What happens during the screening appointment5. How to make a screening appointment|1. Better understanding of the risk of cervical cancer2. Better understanding of the steps that can be taken to reduce the risk of cervical cancer3. Increased uptake of cervical cancer screening|1. Physician feedback2. Uptake of cervical cancer screening among the clinic's patients|None|||
Philip Davies|Вакцинирање против ХПВ и рак на грлото на матката|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Other|English|European Cervical Cancer Association|2010-02-08||Вакцинирање, ХПВ, грлото на матката|This resource contains text and illustrations presenting a summary of a) the risk of cervical cancer, b) the role of the HPV in cervical carcinogenesis, c) the mechanism of action of the HPV vaccines, d) the role of the HPV vaccines in reducing the risk of cervical cancer and e) the recommendations for the use of the HPV vaccines in Macedonia. It is intended to support healthcare providers in the region to educate their patients about cervical cancer screening.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the protection afforded by the HPV vaccines and the recommendations for their use to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What causes cervical cancer2. How HPV vaccination works to prevent cervical cancer3. The benefits and limitations of HPV vaccination4. Who should be vaccinated5. How long vaccination protect lasts6. If boys or men be vaccinated7. Vaccination safety|1. Better understanding of the benefits and drawbacks of HPV vaccination2. Better understanding of the appropriate target populations for HPV vaccination3. Better understanding of the regional recommendations for HPV vaccination|1. Physician feedback2. Uptake of adolescent HPV vaccination among the clinic’s patients|None|||
Philip Davies|Следење и лекување на жени|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Other|English|European Cervical Cancer Association|2010-02-08||абнормален резултат|This resource contains text and illustrations presenting a summary of a) the different non-negative Pap smear results and b) the clinical procedures that are used to follow-up each non-negative result in Macedonia. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the possible results and clinical procedures that may follow a Pap smear to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What non-normal cervical smear results are possible2. What happens next for each possible non-normal result3. What a colposcopy is4. What a biopsy is5. What happens after a biopsy6. What are the possible treatments7. What happens after each treatment|1. Better understanding of the possible Pap smear results2. Better understanding of clinical steps that will be recommended to follow-up each non-negative Pap smear result3. Reduced fear of follow-up and increased compliance with follow-up recommendations|1. Physician feedback2. Follow-up compliance among the clinic's patients|None|||
Philip Davies|Хуман папилома вирус (ХПВ )|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Other|English|European Cervical Cancer Association|2010-02-08||Хуман папилома вирус, ХПВ, грлото на матката|This resource contains text and illustrations presenting a summary of role of the Human papillomavirus (HPV) in cervical carcinogenesis. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cause of cervical cancer to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What causes cervical cancer2. How do you catch genital HPV3. How can you protect yourself4. Can genital HPV be treated5. Will HPV affect pregnancy6. What is HPV testing|1. Better understanding of the role of HPV in cervical carcinogenesis2. Better understanding of the natural history of HPV infection3. Better understanding of the benefits and limitations of HPV testing|1. Physician feedback|None|||
Philip Davies|Преглед (скрининг) за рак на грлото на матката|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Other|English|European Cervical Cancer Association|2010-02-08||Преглед, грлото на матката|This resource contains text and illustrations presenting a summary of a) the risk of cervical cancer, b) the role of screening in reducing this risk, c) the screening recommendations and d) the screening process as conducted in Macedonia. It is intended to support healthcare providers in the region to educate their patients about cervical cancer screening.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cervical cancer screening process to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. Their risk for developing cervical cancer2. That cervical cancer screening can reduce cervical cancer rates by 80% but that regular screening is essential to maximise the protection3. How often they should be screened to obtain the maximum protection4. What happens during the screening appointment5. How to make a screening appointment|1. Better understanding of the risk of cervical cancer2. Better understanding of the steps that can be taken to reduce the risk of cervical cancer3. Increased uptake of cervical cancer screening|1. Physician feedback2. Uptake of cervical cancer screening among the clinic's patients|None|||
Philip Davies|Vaccino contro l’HPV e il cancro cervicale|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Italian|English|European Cervical Cancer Association|2010-01-19||Vaccino, HPV, cancro cervicale|This resource contains text and illustrations presenting a summary of a) the risk of cervical cancer, b) the role of the HPV in cervical carcinogenesis, c) the mechanism of action of the HPV vaccines, d) the role of the HPV vaccines in reducing the risk of cervical cancer and e) the recommendations for the use of the HPV vaccines in Italy. It is intended to support healthcare providers in the region to educate their patients about cervical cancer screening.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the protection afforded by the HPV vaccines and the recommendations for their use to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What causes cervical cancer2. How HPV vaccination works to prevent cervical cancer3. The benefits and limitations of HPV vaccination4. Who should be vaccinated5. How long vaccination protect lasts6. If boys or men be vaccinated7. Vaccination safety|1. Better understanding of the benefits and drawbacks of HPV vaccination2. Better understanding of the appropriate target populations for HPV vaccination3. Better understanding of the regional recommendations for HPV vaccination|1. Physician feedback2. Uptake of adolescent HPV vaccination among the clinic’s patients|None|||
Philip Davies|Follow-up e trattamento di un Pap-test anormale|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Italian|English|European Cervical Cancer Association|2010-01-19||Trattamento, Pap-test anormale|This resource contains text and illustrations presenting a summary of a) the different non-negative Pap smear results and b) the clinical procedures that are used to follow-up each non-negative result in Italy. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers|||Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the possible results and clinical procedures that may follow a Pap smear to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What non-normal cervical smear results are possible2. What happens next for each possible non-normal result3. What a colposcopy is4. What a biopsy is5. What happens after a biopsy6. What are the possible treatments7. What happens after each treatment|1. Better understanding of the possible Pap smear results2. Better understanding of clinical steps that will be recommended to follow-up each non-negative Pap smear result3. Reduced fear of follow-up and increased compliance with follow-up recommendations|1. Physician feedback2. Follow-up compliance among the clinic's patients|None|||
Philip Davies|Papilloma virus umano (HPV) e cancro della cervice uterina|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Italian|English|European Cervical Cancer Association|2010-07-19||Papilloma virus umano, HPV, cancro della cervice uterina|This resource contains text and illustrations presenting a summary of role of the Human papillomavirus (HPV) in cervical carcinogenesis. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cause of cervical cancer to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What causes cervical cancer2. How do you catch genital HPV3. How can you protect yourself4. Can genital HPV be treated5. Will HPV affect pregnancy6. What is HPV testing|1. Better understanding of the role of HPV in cervical carcinogenesis2. Better understanding of the natural history of HPV infection3. Better understanding of the benefits and limitations of HPV testing|1. Physician feedback|None|||
Philip Davies|Screening del cancro della cervice uterina|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Italian|English|European Cervical Cancer Association|2010-01-19||Screening, cancro della cervice uterina|This resource contains text and illustrations presenting a summary of a) the risk of cervical cancer, b) the role of screening in reducing this risk, c) the screening recommendations and d) the screening process as conducted in Italy. It is intended to support healthcare providers in the region to educate their patients about cervical cancer screening.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cervical cancer screening process to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. Their risk for developing cervical cancer2. That cervical cancer screening can reduce cervical cancer rates by 80% but that regular screening is essential to maximise the protection3. How often they should be screened to obtain the maximum protection4. What happens during the screening appointment5. How to make a screening appointment|1. Better understanding of the risk of cervical cancer2. Better understanding of the steps that can be taken to reduce the risk of cervical cancer3. Increased uptake of cervical cancer screening|1. Physician feedback2. Uptake of cervical cancer screening among the clinic's patients|None|||
Philip Davies|HPV ja emakakaelavähi vastu|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Estonian|English|European Cervical Cancer Association|2009-11-10||HPV, emakakaelavähi|This resource contains text and illustrations presenting a summary of a) the risk of cervical cancer, b) the role of the HPV in cervical carcinogenesis, c) the mechanism of action of the HPV vaccines, d) the role of the HPV vaccines in reducing the risk of cervical cancer and e) the recommendations for the use of the HPV vaccines in Estonia. It is intended to support healthcare providers in the region to educate their patients about cervical cancer screening.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the protection afforded by the HPV vaccines and the recommendations for their use to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What causes cervical cancer2. How HPV vaccination works to prevent cervical cancer3. The benefits and limitations of HPV vaccination4. Who should be vaccinated5. How long vaccination protect lasts6. If boys or men be vaccinated7. Vaccination safety|1. Better understanding of the benefits and drawbacks of HPV vaccination2. Better understanding of the appropriate target populations for HPV vaccination3. Better understanding of the regional recommendations for HPV vaccination|1. Physician feedback2. Uptake of adolescent HPV vaccination among the clinic’s patients|None|||
Philip Davies|Jälgimine ja ravi, kui Pap-testi vastus|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Estonian|English|European Cervical Cancer Association|2009-11-10||Jälgimine ja ravi, Pap-testi vastus|This resource contains text and illustrations presenting a summary of a) the different non-negative Pap smear results and b) the clinical procedures that are used to follow-up each non-negative result in Estonia. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the possible results and clinical procedures that may follow a Pap smear to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What non-normal cervical smear results are possible2. What happens next for each possible non-normal result3. What a colposcopy is4. What a biopsy is5. What happens after a biopsy6. What are the possible treatments7. What happens after each treatment|1. Better understanding of the possible Pap smear results2. Better understanding of clinical steps that will be recommended to follow-up each non-negative Pap smear result3. Reduced fear of follow-up and increased compliance with follow-up recommendations|1. Physician feedback2. Follow-up compliance among the clinic's patients|None|||
Philip Davies|Inimese papilloomviirus (HPV) ja emakakaelavähk|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Estonian|English|European Cervical Cancer Association|2009-11-10||Inimese papilloomviirus, HPV|This resource contains text and illustrations presenting a summary of role of the Human papillomavirus (HPV) in cervical carcinogenesis. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cause of cervical cancer to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What causes cervical cancer2. How do you catch genital HPV3. How can you protect yourself4. Can genital HPV be treated5. Will HPV affect pregnancy6. What is HPV testing|1. Better understanding of the role of HPV in cervical carcinogenesis2. Better understanding of the natural history of HPV infection3. Better understanding of the benefits and limitations of HPV testing|1. Physician feedback|None|||
Philip Davies|Emakakaelavähi sõeluuring|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||Estonian|English|European Cervical Cancer Association|2009-11-10||Emakakaelavähi, sõeluuring|This resource contains text and illustrations presenting a summary of a) the risk of cervical cancer, b) the role of screening in reducing this risk, c) the screening recommendations and d) the screening process as conducted in Estonia. It is intended to support healthcare providers in the region to educate their patients about cervical cancer screening.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cervical cancer screening process to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. Their risk for developing cervical cancer2. That cervical cancer screening can reduce cervical cancer rates by 80% but that regular screening is essential to maximise the protection3. How often they should be screened to obtain the maximum protection4. What happens during the screening appointment5. How to make a screening appointment|1. Better understanding of the risk of cervical cancer2. Better understanding of the steps that can be taken to reduce the risk of cervical cancer3. Increased uptake of cervical cancer screening|1. Physician feedback2. Uptake of cervical cancer screening among the clinic's patients|None|||
Philip Davies|Vaccination Against HPV and Cervical Cancer|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||English|English|European Cervical Cancer Association|2009-10-09||Human papillomavirus, vaccination, HPV|This resource contains text and illustrations presenting a summary of a) the risk of cervical cancer, b) the role of the HPV in cervical carcinogenesis, c) the mechanism of action of the HPV vaccines, d) the role of the HPV vaccines in reducing the risk of cervical cancer and e) the recommendations for the use of the HPV vaccines in Ireland. It is intended to support healthcare providers in the region to educate their patients about cervical cancer screening.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the protection afforded by the HPV vaccines and the recommendations for their use to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What causes cervical cancer2. How HPV vaccination works to prevent cervical cancer3. The benefits and limitations of HPV vaccination4. Who should be vaccinated5. How long vaccination protect lasts6. If boys or men be vaccinated7. Vaccination safety|1. Better understanding of the benefits and drawbacks of HPV vaccination2. Better understanding of the appropriate target populations for HPV vaccination3. Better understanding of the regional recommendations for HPV vaccination|1. Physician feedback2. Uptake of adolescent HPV vaccination among the clinic’s patients|None|||
Philip Davies|Follow-up and Treatment of an Abnormal Cervical Smear|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||English|English|European Cervical Cancer Association|2009-10-09||Cervical smear test, borderline, mild dyskaryosis, moderate dyskaryosis, severe dyskaryosis|This resource contains text and illustrations presenting a summary of a) the different non-negative Pap smear results and b) the clinical procedures that are used to follow-up each non-negative result in Ireland. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the possible results and clinical procedures that may follow a Pap smear to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What non-normal cervical smear results are possible2. What happens next for each possible non-normal result3. What a colposcopy is4. What a biopsy is5. What happens after a biopsy6. What are the possible treatments7. What happens after each treatment|1. Better understanding of the possible Pap smear results2. Better understanding of clinical steps that will be recommended to follow-up each non-negative Pap smear result3. Reduced fear of follow-up and increased compliance with follow-up recommendations|1. Physician feedback2. Follow-up compliance among the clinic's patients|None|||
Philip Davies|Human Papillomavirus (HPV) and Cervical Cancer|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||English|English|European Cervical Cancer Association|2009-10-09||Human papillomavirus, HPV|This resource contains text and illustrations presenting a summary of role of the Human papillomavirus (HPV) in cervical carcinogenesis. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cause of cervical cancer to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What causes cervical cancer2. How do you catch genital HPV3. How can you protect yourself4. Can genital HPV be treated5. Will HPV affect pregnancy6. What is HPV testing|1. Better understanding of the role of HPV in cervical carcinogenesis2. Better understanding of the natural history of HPV infection3. Better understanding of the benefits and limitations of HPV testing|1. Physician feedback|None|||
Philip Davies|Cervical Cancer Screening|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||English|English|European Cervical Cancer Association|2009-10-09||Cervical cancer screening, cervical smear test||This resource contains text and illustrations presenting a summary of a) the risk of cervical cancer, b) the role of screening in reducing this risk, c) the screening recommendations and d) the screening process as conducted in Ireland. It is intended to support healthcare providers in the region to educate their patients about cervical cancer screening.|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cervical cancer screening process to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. Their risk for developing cervical cancer2. That cervical cancer screening can reduce cervical cancer rates by 80% but that regular screening is essential to maximise the protection3. How often they should be screened to obtain the maximum protection4. What happens during the screening appointment5. How to make a screening appointment|1. Better understanding of the risk of cervical cancer2. Better understanding of the steps that can be taken to reduce the risk of cervical cancer3. Increased uptake of cervical cancer screening|1. Physician feedback2. Uptake of cervical cancer screening among the clinic's patients|None|||
Philip Davies|Vaccination Against HPV and Cervical Cancer|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||English|English|European Cervical Cancer Association|2008-12-10||Human papillomavirus, vaccination, HPV|his resource contains text and illustrations presenting a summary of a) the risk of cervical cancer, b) the role of the HPV in cervical carcinogenesis, c) the mechanism of action of the HPV vaccines, d) the role of the HPV vaccines in reducing the risk of cervical cancer and e) the recommendations for the use of the HPV vaccines in England. It is intended to support healthcare providers in the region to educate their patients about cervical cancer screening.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the protection afforded by the HPV vaccines and the recommendations for their use to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What causes cervical cancer2. How HPV vaccination works to prevent cervical cancer3. The benefits and limitations of HPV vaccination4. Who should be vaccinated5. How long vaccination protect lasts6. If boys or men be vaccinated7. Vaccination safety|1. Better understanding of the benefits and drawbacks of HPV vaccination2. Better understanding of the appropriate target populations for HPV vaccination3. Better understanding of the regional recommendations for HPV vaccination|1. Physician feedback2. Uptake of adolescent HPV vaccination among the clinic’s patients|None|||
Philip Davies|Follow-up and Treatment of an Abnormal Cervical Smear|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||English|English|European Cervical Cancer Association|2008-12-10||Cervical smear test, borderline, mild dyskaryosis, moderate dyskaryosis, severe dyskaryosis|This resource contains text and illustrations presenting a summary of a) the different non-negative Pap smear results and b) the clinical procedures that are used to follow-up each non-negative result in England. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the possible results and clinical procedures that may follow a Pap smear to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What non-normal cervical smear results are possible2. What happens next for each possible non-normal result3. What a colposcopy is4. What a biopsy is5. What happens after a biopsy6. What are the possible treatments7. What happens after each treatment|1. Better understanding of the possible Pap smear results2. Better understanding of clinical steps that will be recommended to follow-up each non-negative Pap smear result3. Reduced fear of follow-up and increased compliance with follow-up recommendations|1. Physician feedback2. Follow-up compliance among the clinic's patients|None|||
Philip Davies|Human Papillomavirus (HPV) and Cervical Cancer|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||English|English|European Cervical Cancer Association|2008-12-10||Human papillomavirus, HPV|This resource contains text and illustrations presenting a summary of role of the Human papillomavirus (HPV) in cervical carcinogenesis. It is intended to support healthcare providers in the region to educate their patients about cervical cancer causation, screening and prevention.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cause of cervical cancer to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. What causes cervical cancer2. How do you catch genital HPV3. How can you protect yourself4. Can genital HPV be treated5. Will HPV affect pregnancy6. What is HPV testing|1. Better understanding of the role of HPV in cervical carcinogenesis2. Better understanding of the natural history of HPV infection3. Better understanding of the benefits and limitations of HPV testing|1. Physician feedback|None|||
Philip Davies|Cervical Cancer Screening|http://www.ecca.info/wa/ecca-publications/brochures.html|||Attribution Non-commercial No Derivatives (by-nc-nd)||English|English|European Cervical Cancer Association|2008-12-10||Screening, cervical smear test|This resource contains text and illustrations presenting a summary of a) the risk of cervical cancer, b) the role of screening in reducing this risk, c) the screening recommendations and d) the screening process as conducted in England. It is intended to support healthcare providers in the region to educate their patients about cervical cancer screening.|PDF/print|Text with illustrations|Primary healthcare providers||General public|Primary healthcare provider consultation with patient|The resource is intended to support primary healthcare providers to verbally communicate information about the cervical cancer screening process to patients by structuring the discussion, ensuring all pertinent facts are covered and providing a ready source of review for the patient. The healthcare provider should verbally present a summary of the information contained in the brochure in the order it is presented while using the illustrations in the brochure to emphasise the important points and answering any questions the patient may have. The healthcare provider should draw the patient's attention to the ECCA website address that is listed in the brochure and give the patient with a copy of the brochure to take home so that later review of the information is possible. The resource should not be used to replace the verbal discussion of cervical cancer prevention.|After the educational session with the healthcare provider, the patient should know:1. Their risk for developing cervical cancer2. That cervical cancer screening can reduce cervical cancer rates by 80% but that regular screening is essential to maximise the protection3. How often they should be screened to obtain the maximum protection4. What happens during the screening appointment5. How to make a screening appointment|1. Better understanding of the risk of cervical cancer2. Better understanding of the steps that can be taken to reduce the risk of cervical cancer3. Increased uptake of cervical cancer screening|1. Physician feedback2. Uptake of cervical cancer screening among the clinic's patients|None|||
Eleni Kaldoudi|Basic Principles of Radiation Physics|http://iris.med.duth.gr/elearning/mod/resource/view.php?id=865|||Attribution Non-commercial Share Alike (by-nc-sa)||Greek|English|Eleni Kaldoudi|2010-06-10|Ε. Καλδούδη, «Βασικές αρχές της φυσικής των ακτινοβολιών», Παρουσίαση στα πλαίσια του Σεμιναρίου «Ακτινοπροστασία για χειριστές ιατρικών μηχανημάτων ιοντιζουσών ακτινοβολιών», Ελληνική Επιτροπή Ατομικής Ενέργειας, Αλεξανδρούπολη 11-13 Ιουνίου, 2010|radiation physics|This resource is intended as a 2-hour lecture on the priciples of radiation physics for non-medical healthcare personnel, e.g. radiographers.|A WinRar zip archive containing a 65-slide powerpoint presentation (~1.8MB).|lecture presentation|medicine, paramedics, technologists|radiology|continuing education|Recommended as an introduction to the priciples of radiation physics, as part of continuing education for medical personnel and technologists in the field of radiology.|The powepoint presentation contains useful animation, so it is best viewed in the slide show mode of the powerpoint.|||||http://iris.med.duth.gr/elearning/course/view.php?id=104||The presentation is repurposed from a similar presentation created a support material for seminars to radiographers by the Greek Commision for Atomic Energy and the Dept. of Medical Physics, Kapodistrian University of Athens. The main layout is the same, however more material is added, the graphics and information presentation has been changed and animations have been added.
